Related Experiment Video

Updated: Sep 29, 2025

Author Spotlight: Reprogramming Cancer Cells to iPSCs to Study Disease Progression and Treatment Targets
07:08

Author Spotlight: Reprogramming Cancer Cells to iPSCs to Study Disease Progression and Treatment Targets

Published on: February 2, 2024

939

Molecular Pathology of Pancreatic Cancer

Eva Karamitopoulou1,2

  • 1Pancreatic Cancer Research, Institute of Pathology, University of Bern, CH-3008 Bern, Switzerland.

Cancers
|March 25, 2022
PubMed

Insights

Pancreatic ductal adenocarcinoma (PDAC) is a deadly cancer resistant to therapy. Early detection and novel treatments are crucial for improving patient survival rates.

Area of Science:

  • Oncology
  • Cancer Biology
  • Medical Research

Background:

  • Pancreatic ductal adenocarcinoma (PDAC) is an aggressive cancer.
  • PDAC often presents at advanced stages, limiting treatment options.
  • Current therapies show limited efficacy against PDAC.

Discussion:

  • The aggressive nature of PDAC necessitates innovative therapeutic strategies.
  • Understanding PDAC biology is key to overcoming treatment resistance.
  • Improving early detection methods can enhance surgical resection rates.

Key Insights:

  • PDAC exhibits significant resistance to established treatments.
  • Late-stage diagnosis is a major challenge in managing PDAC.
  • Surgical resection is feasible for a small fraction of patients.

Outlook:

  • Future research should focus on novel therapeutic targets for PDAC.
  • Advancements in early detection could improve patient outcomes.
  • Developing effective combination therapies is essential for PDAC treatment.

More Related Videos

Isolation of Proximal Fluids to Investigate the Tumor Microenvironment of Pancreatic Adenocarcinoma05:44

Isolation of Proximal Fluids to Investigate the Tumor Microenvironment of Pancreatic Adenocarcinoma

Published on: November 5, 2020

4.6K
Comparative Lesions Analysis Through a Targeted Sequencing Approach08:16

Comparative Lesions Analysis Through a Targeted Sequencing Approach

Published on: November 5, 2019

6.9K

Related Concept Videos

Tumor Progression02:07

Tumor Progression

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.5K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.9K